150 related articles for article (PubMed ID: 3747914)
1. Drug disposition and dosing in hepatic disease.
Somogyi A; Rolan P
Med J Aust; 1986 Sep; 145(6):284-6, 289. PubMed ID: 3747914
[No Abstract] [Full Text] [Related]
2. Drug disposition in liver disease.
Fruncillo RJ
Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
[No Abstract] [Full Text] [Related]
3. Drug disposition and liver disease.
Wilkinson GR; Schenker S
Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104
[No Abstract] [Full Text] [Related]
4. [Side effects of drugs--predictable hazards for patients with liver disease].
Baumgarten R
Z Arztl Fortbild (Jena); 1983; 77(9):373-5. PubMed ID: 6880279
[No Abstract] [Full Text] [Related]
5. Hepatic circulation and drug disposition in cirrhosis.
Shand DG
Gastroenterology; 1979 Jul; 77(1):185-6. PubMed ID: 447017
[No Abstract] [Full Text] [Related]
6. Drug disposition in liver disease.
Shand DG
N Engl J Med; 1977 Jun; 296(26):1527-8. PubMed ID: 865536
[No Abstract] [Full Text] [Related]
7. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.
Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH
Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671
[TBL] [Abstract][Full Text] [Related]
8. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism.
Farrell GC; Cooksley WG; Hart P; Powell LW
Gastroenterology; 1978 Oct; 75(4):580-8. PubMed ID: 710827
[TBL] [Abstract][Full Text] [Related]
9. Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
Narang AP; Datta DV; Nath N; Mathur VS
Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177
[TBL] [Abstract][Full Text] [Related]
10. Hepatic drug metabolizing capacity of patients of cirrhosis before and after clinico-biochemical recovery.
Chauhan CK; Nanivadekar SA; Billimoria FR
Indian J Physiol Pharmacol; 1989; 33(1):63-6. PubMed ID: 2737749
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics in liver cirrhosis].
Ackermann E
Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389
[TBL] [Abstract][Full Text] [Related]
12. [Drug dosing in chronic hepatic disease (author's transl)].
Gugler R; Eichelbaum M
Leber Magen Darm; 1981 Apr; 11(2):81-7. PubMed ID: 7015045
[TBL] [Abstract][Full Text] [Related]
13. Effects of liver disease and of aging on the disposition and elimination of sedatives.
Schenker S
Trans Am Clin Climatol Assoc; 1978; 89():91-9. PubMed ID: 30206
[No Abstract] [Full Text] [Related]
14. Altered hepatic blood flow and drug disposition.
Nies AS; Shand DG; Wilkinson GR
Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954
[TBL] [Abstract][Full Text] [Related]
15. [Handling of drugs by cirrhotic patients].
Danan G; Pariente A
Rev Prat; 1986 Sep; 36(39):2298-308. PubMed ID: 3809928
[No Abstract] [Full Text] [Related]
16. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
Perrier D; Gibaldi M
J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
[No Abstract] [Full Text] [Related]
17. [Metabolism of phenylbutazone in the liver (author's transl)].
González Macías J; De Castro del Pozo S
Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107
[TBL] [Abstract][Full Text] [Related]
18. The daily rhythm of cortisolemia in hepatic cirrhosis.
Ruzyllo E; Dzieniszewski J; Milewski B; Krygier T
Mater Med Pol; 1973; 5(1):9-16. PubMed ID: 4774849
[No Abstract] [Full Text] [Related]
19. [Drug disposition in cirrhosis (author's transl)].
Métreau JM
Gastroenterol Clin Biol; 1981 Nov; 5(11):1052-7. PubMed ID: 7308677
[No Abstract] [Full Text] [Related]
20. Drugs and the ageing liver.
James OF
J Hepatol; 1985; 1(4):431-5. PubMed ID: 3902953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
